Home / COQ8A Knockout Cell Lines

COQ8A Knockout Cell Lines

Gene: COQ8A

Official Full Name: coenzyme Q8Aprovided by HGNC

Gene Summary: This gene encodes a mitochondrial protein similar to yeast ABC1, which functions in an electron-transferring membrane protein complex in the respiratory chain. It is not related to the family of ABC transporter proteins. Expression of this gene is induced by the tumor suppressor p53 and in response to DNA damage, and inhibiting its expression partially suppresses p53-induced apoptosis. Alternatively spliced transcript variants have been found; however, their full-length nature has not been determined. [provided by RefSeq, Jul 2008]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO03946 COQ8A Knockout cell line (HeLa) Human COQ8A 1:3~1:6 Negative Online Inquiry
KO03947 COQ8A Knockout cell line (HCT 116) Human COQ8A 1:2~1:4 Negative Online Inquiry
KO03948 COQ8A Knockout cell line (HEK293) Human COQ8A 1:3~1:6 Negative Online Inquiry
KO03949 COQ8A Knockout cell line (A549) Human COQ8A 1:3~1:4 Negative Online Inquiry

Background

COQ8A Gene Knockout Cell Lines are genetically engineered cellular models in which the COQ8A gene has been selectively disrupted. This innovative tool plays a pivotal role in studying mitochondrial function and bioenergetics, given that COQ8A is crucial for coenzyme Q10 biosynthesis, a critical component in the electron transport chain. By knocking out the COQ8A gene, researchers can effectively manipulate cellular pathways to investigate the implications of impaired coenzyme Q10 synthesis on cellular metabolism and disease processes, including neurodegenerative disorders and cardiomyopathies.

The primary function of these knockout cell lines is to serve as a platform for dissecting the molecular mechanisms underlying mitochondrial dysfunction. Through the absence of COQ8A, scientists can observe consequential alterations in mitochondrial morphology, energy production, and apoptotic signaling pathways. This capability enables a deeper understanding of how variations in mitochondrial efficiency can influence cellular physiology and pathology.

In the realm of research and clinical settings, COQ8A Gene Knockout Cell Lines are invaluable for drug discovery initiatives, biomarker identification, and the development of therapeutic strategies targeting mitochondrial diseases. Their use can pave the way for novel insights into patient-specific genetic variations influencing disease outcomes.

What sets these cell lines apart from traditional models is their precise genetic modification, which ensures a high degree of specificity in the observed outcomes, thus providing researchers with reliable and reproducible data. Further, these knockout models facilitate the integration of CRISPR technology, enhancing opportunities for combinatorial studies.

The value of COQ8A Gene Knockout Cell Lines extends beyond just basic research; they are essential for clinicians and pharmaceutical companies aiming to advance treatments for mitochondrial-related pathologies. By using these cell lines, users can accelerate their research timelines and enhance the quality of their findings.

With years of expertise in providing high-quality biological products, our company is committed to empowering researchers and clinicians with tools that facilitate groundbreaking discoveries in the field of biomedical research.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.